The pharmacogenetics of treatment with quetiapine
M Ortega-Ruiz, P Soria-Chacartegui… - Future …, 2022 - mdpi.com
Quetiapine is a second-generation antipsychotic used for the treatment of schizophrenia,
depression and bipolar disorder. The aim of this traditional review was to summarize the …
depression and bipolar disorder. The aim of this traditional review was to summarize the …
Pharmacogenetics of Antipsychotic Treatment in Schizophrenia
Antipsychotics are the mainstay treatment for schizophrenia. There is large variability
between individuals in their response to antipsychotics, both in efficacy and adverse effects …
between individuals in their response to antipsychotics, both in efficacy and adverse effects …
Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions
EE Tsermpini, T Terzi, BK Plesničar, V Dolžan - Psychiatric Genomics, 2022 - Elsevier
This chapter presents the growing evidence that suggests that pharmacogenetic variability
contributes to interindividual differences in response to antipsychotics and related adverse …
contributes to interindividual differences in response to antipsychotics and related adverse …
Pharmacogenetics of psychotropic drugs and genetic influences on adverse drug reactions
I Austin-Zimmerman - 2022 - discovery.ucl.ac.uk
In this thesis, I investigate the impact of genetic variation on adverse drug reactions to
psychotropic medications, with a focus on the metabolic and sleep related side effects of …
psychotropic medications, with a focus on the metabolic and sleep related side effects of …
Method for predicting the response of antipsychotic drugs
S Jamain, R Troudet - US Patent App. 17/606,099, 2022 - Google Patents
(57) ABSTRACT A fundamental shortcoming in the current treatment of schizophrenia is the
lack of valid criteria to predict who will respond to antipsychotic treatment. The identification …
lack of valid criteria to predict who will respond to antipsychotic treatment. The identification …